J

Jinyu Bio-Technology Co Ltd
SSE:600201

Watchlist Manager
Jinyu Bio-Technology Co Ltd
SSE:600201
Watchlist
Price: 7.13 CNY -0.14% Market Closed
Market Cap: 8B CNY
Have any thoughts about
Jinyu Bio-Technology Co Ltd?
Write Note

Jinyu Bio-Technology Co Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jinyu Bio-Technology Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
J
Jinyu Bio-Technology Co Ltd
SSE:600201
Total Current Liabilities
ÂĄ770.5m
CAGR 3-Years
6%
CAGR 5-Years
13%
CAGR 10-Years
11%
Beigene Ltd
HKEX:6160
Total Current Liabilities
ÂĄ12.8B
CAGR 3-Years
22%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Current Liabilities
ÂĄ4.1B
CAGR 3-Years
23%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Current Liabilities
ÂĄ2.7B
CAGR 3-Years
48%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Current Liabilities
ÂĄ22.7B
CAGR 3-Years
27%
CAGR 5-Years
32%
CAGR 10-Years
71%
Imeik Technology Development Co Ltd
SZSE:300896
Total Current Liabilities
ÂĄ297.7m
CAGR 3-Years
49%
CAGR 5-Years
46%
CAGR 10-Years
N/A
No Stocks Found

Jinyu Bio-Technology Co Ltd
Glance View

Market Cap
8B CNY
Industry
Biotechnology

Jinyu Bio-Technology Co Ltd., a hallmark of scientific innovation and agricultural care, operates at the intersection of biotech and animal health services, focusing primarily on the production of vaccines for livestock. Founded with the vision to enhance animal well-being and agricultural productivity, the company's trajectory has been marked by a commitment to research and development. This dedication is evidenced by its expansive portfolio, which features an array of vaccines aimed at safeguarding livestock against prevalent and virulent diseases. By investing heavily in R&D, Jinyu ensures that its product offerings remain at the frontier of technological advancement and efficacy. The company's modern facilities, equipped with state-of-the-art technology, facilitate the production of high-quality vaccines that adhere to international standards. The company's business model is intricately tied to its strategic positioning within the agricultural ecosystem. By catering to a critical segment—livestock and poultry farmers—Jinyu not only supplies essential vaccines but also provides veterinary services and support, ensuring a holistic approach to animal health. This dual role as a product supplier and service provider enables Jinyu Bio-Technology Co Ltd. to forge long-lasting relationships with its clientele, enhancing customer loyalty and creating a stable revenue stream. Moreover, its efforts in capturing emerging markets, particularly in regions where agricultural development is accelerating, signal a forward-thinking approach that seeks to tap into new growth avenues. Through these strategies, Jinyu continues to reinforce its stature as a pivotal player in the animal health domain, working diligently to marry profitability with sustainable agricultural development.

Intrinsic Value
10.74 CNY
Undervaluation 34%
Intrinsic Value
Price
J

See Also

What is Jinyu Bio-Technology Co Ltd's Total Current Liabilities?
Total Current Liabilities
770.5m CNY

Based on the financial report for Sep 30, 2024, Jinyu Bio-Technology Co Ltd's Total Current Liabilities amounts to 770.5m CNY.

What is Jinyu Bio-Technology Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
11%

Over the last year, the Total Current Liabilities growth was -5%. The average annual Total Current Liabilities growth rates for Jinyu Bio-Technology Co Ltd have been 6% over the past three years , 13% over the past five years , and 11% over the past ten years .

Back to Top